Literature DB >> 20146354

Precise conditional immortalization of mouse cells using tetracycline-regulated SV40 large T-antigen.

Konstantinos Anastassiadis1, Maria Rostovskaya, Sandra Lubitz, Stefanie Weidlich, A Francis Stewart.   

Abstract

Cellular immortalization provides a way for expansion and subsequent molecular characterization of rare cell types. Ideally, immortalization can be achieved by the reversible expression of immortalizing proteins. Here, we describe the use of conditional immortalization based on a modified tetracycline-regulated system for the expression of SV40 large T-antigen in embryonic stem (ES) cells and mice. The modified system relies on a codon improved reverse tetracycline transactivator (irtTA) fused to the ligand-binding domain (LBD) of the androgen receptor (irtTA-ABD) or of a mutated glucocorticoid receptor (irtTA-GBD*). Induction of T-antigen is conferred only after addition of two ligands, one to activate the LBD (mibolerone for irtTA-ABD or dexamethasone for irtTA-GBD*) and one to activate the tetracycline transactivator (doxycycline). In ES cells, changes in gene expression upon large T induction were limited and reversible upon deinduction. Similarly, expression of T-antigen was very tightly regulated in mice. We have isolated and expanded bone marrow mesenchymal stem cells that could be genetically manipulated and maintained their differentiation properties after several passages of expansion under conditions that induce the expression of large T-antigen. 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146354     DOI: 10.1002/dvg.20605

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  14 in total

1.  Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes.

Authors:  Eva Ramboer; Tamara Vanhaecke; Vera Rogiers; Mathieu Vinken
Journal:  Methods Mol Biol       Date:  2015

2.  A genotype-phenotype screening system using conditionally immortalized immature dendritic cells.

Authors:  Liwei Zhao; Peng Liu; Wei Xie; Shuai Zhang; Sebastian Thieme; Laurence Zitvogel; Guido Kroemer; Oliver Kepp
Journal:  STAR Protoc       Date:  2021-08-12

3.  Generation of inducible immortalized dendritic cells with proper immune function in vitro and in vivo.

Authors:  Cornelia Richter; Sebastian Thieme; Joanna Bandoła; Magdalena Laugsch; Konstantinos Anastassiadis; Sebastian Brenner
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

4.  Differential expression of surface markers in mouse bone marrow mesenchymal stromal cell subpopulations with distinct lineage commitment.

Authors:  Maria Rostovskaya; Konstantinos Anastassiadis
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

5.  Immortalized mesenchymal stem cells: an alternative to primary mesenchymal stem cells in neuronal differentiation and neuroregeneration associated studies.

Authors:  Min Gong; Yang Bi; Wei Jiang; Yun Zhang; Li Chen; Nali Hou; Youxue Liu; Xiaoping Wei; Jie Chen; Tingyu Li
Journal:  J Biomed Sci       Date:  2011-11-25       Impact factor: 8.410

6.  Review of the history and current status of cell-transplant approaches for the management of neuropathic pain.

Authors:  Mary J Eaton; Yerko Berrocal; Stacey Q Wolfe; Eva Widerström-Noga
Journal:  Pain Res Treat       Date:  2012-06-14

7.  Germline transgenic methods for tracking cells and testing gene function during regeneration in the axolotl.

Authors:  Shahryar Khattak; Maritta Schuez; Tobias Richter; Dunja Knapp; Saori L Haigo; Tatiana Sandoval-Guzmán; Kristyna Hradlikova; Annett Duemmler; Ryan Kerney; Elly M Tanaka
Journal:  Stem Cell Reports       Date:  2013-06-04       Impact factor: 7.765

8.  Patched1 and Patched2 inhibit Smoothened non-cell autonomously.

Authors:  Brock Roberts; Catalina Casillas; Astrid C Alfaro; Carina Jägers; Henk Roelink
Journal:  Elife       Date:  2016-08-23       Impact factor: 8.140

9.  Transplantation of Immortalized CD34+ and CD34- Adipose-Derived Stem Cells Improve Cardiac Function and Mitigate Systemic Pro-Inflammatory Responses.

Authors:  Jong-Ho Kim; Seung-Cheol Choi; Chi-Yeon Park; Jae-Hyoung Park; Ji-Hyun Choi; Hyung-Joon Joo; Soon-Jun Hong; Do-Sun Lim
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

Review 10.  Strategies for immortalization of primary hepatocytes.

Authors:  Eva Ramboer; Bram De Craene; Joery De Kock; Tamara Vanhaecke; Geert Berx; Vera Rogiers; Mathieu Vinken
Journal:  J Hepatol       Date:  2014-06-06       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.